1.21
price down icon3.20%   -0.04
after-market Handel nachbörslich: 1.22 0.01 +0.83%
loading

Pds Biotechnology Corporation Aktie (PDSB) Neueste Nachrichten

pulisher
01:07 AM

Is PDS Biotechnology Corporation stock a good hedge against inflationSuperior risk-adjusted returns - jammulinksnews.com

01:07 AM
pulisher
Jul 23, 2025

PDS Biotechnology Corporation Stock Analysis and ForecastDynamic profit expansion - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about PDS Biotechnology Corporation stockMarket-crushing stock picks - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

PDS Biotechnology Publishes Versamune® HPV Abstracts at ASCO - MSN

Jul 22, 2025
pulisher
Jul 22, 2025

What drives PDS Biotechnology Corporation stock priceFree Stock Movement Tracking - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

How PDS Biotechnology Corporation stock performs during market volatilityHigh Yield Stock Selection - Newser

Jul 22, 2025
pulisher
Jul 20, 2025

Is PDS Biotechnology Corporation a good long term investmentSuperior capital gains - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 15, 2025

Why PDS Biotechnology Corporation stock attracts strong analyst attentionFree Stock Market Knowledge Sharing - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes PDS Biotechnology Corporation stock price move sharplyFree Access to Investment Community - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

PDS Biotechnology stock advances as Phase 2 trial meets expansion criteria - Investing.com Nigeria

Jul 11, 2025
pulisher
Jul 11, 2025

PDS Biotechnology completes recruitment for stage one of colorectal cancer trial - Yahoo Finance

Jul 11, 2025
pulisher
Jul 10, 2025

PDS Biotechnology Corporation Announces Colorectal Cancer Cohort of Phase 2 Clinical Trial with PDS01ADC Met Criteria for Expansion to Stage 2 Following Positive Stage 1 Results - MarketScreener

Jul 10, 2025
pulisher
Jul 10, 2025

PDS Biotechnology stock rises after trial meets criteria for expansion By Investing.com - Investing.com Nigeria

Jul 10, 2025
pulisher
Jul 10, 2025

PDS Biotechnology stock rises after trial meets criteria for expansion - Investing.com Australia

Jul 10, 2025
pulisher
Jul 10, 2025

PDS Biotech's PDS01ADC: A Breakthrough in Cytokine Therapy for Metastatic Colorectal Cancer - AInvest

Jul 10, 2025
pulisher
Jul 10, 2025

PDS Biotech Announces Colorectal Cancer Cohort of Phase 2 Clinical Trial with PDS01ADC Met Criteria for Expansion to Stage 2 Following Positive Stage 1 Results - The Manila Times

Jul 10, 2025
pulisher
Jul 10, 2025

PDS Biotech Achieves Crucial Phase 2 Milestone: Colorectal Cancer Drug Shows Promising Early Results - Stock Titan

Jul 10, 2025
pulisher
Jul 01, 2025

PDS Biotechnology (PDSB) Retains "Buy" Rating with Price Target Unchanged | PDSB Stock News - GuruFocus

Jul 01, 2025
pulisher
Jun 18, 2025

PDSB’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com

Jun 18, 2025
pulisher
Jun 17, 2025

Transcript : PDS Biotechnology CorporationSpecial Call - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

PDS Biotechnology holds a conference call - TipRanks

Jun 17, 2025
pulisher
Jun 14, 2025

PDS Biotechnology (NASDAQ:PDSB) Stock Rating Lowered by Wall Street Zen - Defense World

Jun 14, 2025
pulisher
Jun 14, 2025

HC Wainwright Issues Pessimistic Estimate for PDSB Earnings - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

PDS Biotechnology Co. (NASDAQ:PDSB) Shares Sold by Millennium Management LLC - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

Two Sigma Investments LP Raises Stock Holdings in PDS Biotechnology Co. (NASDAQ:PDSB) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

PDS Biotechnology (NASDAQ:PDSB) Receives Buy Rating from HC Wainwright - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

PDS Biotech expands equity incentive plan By Investing.com - Investing.com Canada

Jun 11, 2025
pulisher
Jun 11, 2025

PDS Biotech expands equity incentive plan - Investing.com

Jun 11, 2025
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Kapitalisierung:     |  Volumen (24h):